Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Warrant Indenture
View:
Post by 2O2Ovision on Aug 28, 2023 7:29am

Warrant Indenture

Document was recently filed without any suprises as we already knew about the accelarated warrant expiry if this reaches $6.50, but, article 5.1 is interesting. The corporation reserves the right to buy back the warrants under private contract at a price deemed acceptable by the BOD. I have to say this is above my pay grade but anyone know if this is a boiler plate clause in these types of situation, or are we to believe ONC hopes to come into some funds (Adlai milestones?) to save a little face on these cheap 5 year warrants prior to BO talks? Probably grasping at straws but wondering if anyone has seen this before. Thanks.
Comment by 13X2413 on Aug 28, 2023 10:56am
Way over my head, but what I have seen before is this thing not able to gain any traction. Something smells here. 
Comment by Lesalpes29 on Aug 28, 2023 11:09am
Killing any momentum week aftet week. Frustration will push some to sell. Let's go Matt get back from vacations with your heavy sun tan and your new fresh and free options... 
Comment by 13X2413 on Aug 28, 2023 11:13am
With my money too. The only way to handle this is to trade my way out. Investing not in the cards for this piece of c**p. It's topped out. 
Comment by Angler101 on Aug 28, 2023 12:49pm
Adios cabrone
Comment by Buckhenry on Aug 28, 2023 1:59pm
Maybe the forever pumpers can tell us some bedtime stories about all the companies that have been bought out for gazillions. I get all gitty  when I read those posts????
Comment by Buckhenry on Aug 28, 2023 4:08pm
Where are pumpers when we need them most to boost our spirits and give us a warm fuzzy feeling???  I know I know... just please be patient!!!!
Comment by Buckhenry on Aug 28, 2023 10:16pm
"Big pharmas  acquisition "... unnoteable  must be smokin  sumin  special  tonight.  And it ain't legal.... in most states.  
Comment by Noteable on Aug 28, 2023 4:49pm
Unlike what was falsely stated and erroneously represented Article 5.1 of the Warrant Indenture dated as of the 8th day of August, 2023.states the following: - Page 31 - ARTICLE 5 RIGHTS OF THE CORPORATION AND COVENANTS 5.1 Optional Purchases by the Corporation. Subject to compliance with applicable securities legislation and approval of applicable regulatory authorities, the Corporation ...more  
Comment by Noteable on Aug 28, 2023 4:55pm
2020vision is obviously a plain Jane, Janus-faced prevaricator, as are his followers.
Comment by Noteable on Aug 28, 2023 5:07pm
 Plain Jane, Janus-faced prevaricator ... Member Since: August 17, 2023
Comment by Noteable on Aug 28, 2023 5:24pm
Plain Jane, Janus-faced prevaricators falsetto went out to explicitly misrepresent Article 5.1 of the Warrant Indenture.
Comment by Noteable on Aug 28, 2023 8:33pm
OK .. maybe I was a little harsh. ONCY does reserve the right to buy back whatever of the warrants issued - whenever it chooses. So if the warrant holders want in on the stock .. they better decide soon to move on the exercising of their options, before ONCY does in the company's advance preparations for Big Pharma's acquisition. The time for one is nearing.
Comment by Noteable on Aug 28, 2023 11:28pm
ESMO is around the corner and 2 Phase 3 cliniical trials will come soon after. So yes .. where there's smoke .. there's fire 
Comment by Noteable on Aug 28, 2023 11:35pm
And since the FTC has decided to pause their challenge to the US$28 Billion takeover of Horizon by Amgen .. the M&A activies of Big Pharma are about to ramp up in Q4 2023. So let the smoke start billowing.
Comment by 2O2Ovision on Aug 29, 2023 7:54am
Glad you finally read the article instead of falsely acusing people. The accerlarated expiry is in the propspectus which we've known about for about a month. I din't say that was in 5.1. Still waiting to see if anyone has seen such a clause before.
Comment by Lesalpes29 on Aug 29, 2023 8:00am
Thsnk you for your finding. Didn't see this before. See it as a sign of possible negociations with BP. GL
Comment by Lesalpes29 on Aug 29, 2023 8:03am
Or maybe to offer them to ower new friendly institionnal investor. Anyway see it possitively. 
Comment by Noteable on Aug 29, 2023 10:44am
The warrants were attached to the purchase of the underlying stock and the warrants have no inherent value other than giving the older the right to purchase the stock at US$2.81 per share. Since the warrants have no inherent value article 5.1 provides that ONCY can purchase the warrants for as little as US$0.01 per warrant ...more  
Comment by Noteable on Aug 29, 2023 10:46am
Should read: ...the warrants have no inherent value other than giving the holder the right to purchase the stock at US$2.81 per share ...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities